Literature DB >> 11488418

Reproducibility of biopsy grade in Sjögren's syndrome.

I Al-Hashimi1, J M Wright, C A Cooley, M E Nunn.   

Abstract

The purpose of this study was to examine the reproducibility of biopsy grades at various tissue depths in Sjögren's syndrome. The biopsy grades of 38 minor salivary gland biopsies were examined at 6 microm, 50 microm, 100 microm, 150 microm, 200 microm, and 250 microm tissue depths. Tissue sections were stained with routine hematoxylin and eosin, graded I-IV, and compared with the initial "baseline" biopsy grade. The majority of the biopsies showed a wide range of grade variability at all depths. No tissue depth was consistently reproducible for any grade (P> or =0.41, 0.64, 0.91, and 0.20, respectively). The difference between baseline grades and grades of deeper sections was sufficient to impact the diagnosis of Sjögren's syndrome in approximately 60% of the biopsies (P<0.001). The overall result of this study suggests that examination of multiple sections of minor salivary gland biopsies is advisable to improve the reliability of the grade when evaluating Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488418     DOI: 10.1034/j.1600-0714.2001.300705.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  10 in total

1.  MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome.

Authors:  Ilias Alevizos; Stefanie Alexander; R James Turner; Gabor G Illei
Journal:  Arthritis Rheum       Date:  2011-02

Review 2.  Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.

Authors:  Ibtisam Al-Hashimi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Identification of potential genomic biomarkers for Sjögren's syndrome using data pooling of gene expression microarrays.

Authors:  Sadik A Khuder; Ibtisam Al-Hashimi; Anand B Mutgi; Nezam Altorok
Journal:  Rheumatol Int       Date:  2014-10-20       Impact factor: 2.631

Review 4.  [Is bioptic assurance reasonable in patients with Sjögren's syndrome? From focus score to diagnosing vasculitides].

Authors:  V Krenn; M Jakobs; J Kriegsmann; M G Krukemeyer; A Rieger
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

5.  [Labial salivary gland biopsy in Sjögren's syndrome].

Authors:  A Dankof; L Morawietz; E Feist
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

6.  Sjögren Syndrome without Focal Lymphocytic Infiltration of the Salivary Glands.

Authors:  Rohan Sharma; Kaustubh S Chaudhari; Biji T Kurien; Kiely Grundahl; Lida Radfar; David M Lewis; Christopher J Lessard; He Li; Astrid Rasmussen; Kathy L Sivils; R Hal Scofield
Journal:  J Rheumatol       Date:  2019-05-15       Impact factor: 4.666

7.  Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.

Authors:  L A Aqrawi; K Skarstein; G Øijordsbakken; K A Brokstad
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

8.  Discovery of putative salivary biomarkers for Sjögren's syndrome using high resolution mass spectrometry and bioinformatics.

Authors:  Driss Zoukhri; Ian Rawe; Mabi Singh; Ashley Brown; Claire L Kublin; Kevin Dawson; William F Haddon; Earl L White; Kathleen M Hanley; Daniel Tusé; Wasyl Malyj; Athena Papas
Journal:  J Oral Sci       Date:  2012-03       Impact factor: 1.630

9.  A follow-up study of minimally invasive lip biopsy in the diagnosis of Sjögren's syndrome.

Authors:  Heikki Teppo; Matti Revonta
Journal:  Clin Rheumatol       Date:  2006-11-25       Impact factor: 3.650

10.  Multilevel examination of minor salivary gland biopsy for Sjogren's syndrome significantly improves diagnostic performance of AECG classification criteria.

Authors:  Patrizia Morbini; Antonio Manzo; Roberto Caporali; Oscar Epis; Chiara Villa; Carmine Tinelli; Enrico Solcia; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2005-01-17       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.